Ignite Creation Date:
2024-05-06 @ 5:57 PM
Last Modification Date:
2024-10-26 @ 2:38 PM
Study NCT ID:
NCT05491525
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2022-07-28
Brief Title:
A Study of Vibegron in Pediatric Participants 2 Years to Less Than 18 Years of Age With NDO and on CIC
Sponsor:
Urovant Sciences GmbH
Organization:
Urovant Sciences GmbH
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Neurogenic Detrusor Overactivity |
Keywords:
| Name | View |
|---|---|
| Transverse myelitis | View |
| Neurogenic Detrusor Overactivity | View |
| Vibegron | View |
| Clean Intermittent Catheterization | View |
| Beta-3 Adrenergic Receptor Agonist | View |
| Maximum Cystometric Capacity | View |
| Spinal Dysraphism | View |
| Spina Bifida | View |
| Myelomeningocele | View |
| Meningocele | View |
| Spinal cord injury | View |